US Vice President JD Vance ordered the deferral of $1.3 billion in federal Medicaid funds to California, citing fraud concerns. California officials argue the rise in spending is tied to expanded home care services, not misconduct. The state Attorney General says the action is unlawful and will challenge it, following similar moves aimed at other states and healthcare providers.
Trump has unveiled a deal with Regeneron aimed at lowering US healthcare costs under the most-favored-nation push. The company will cut prices for its drugs on Medicaid, and Praluent, a cholesterol medicine, is set to be sold for $225 on Trump’s discounted drug website. Regeneron also pledges major investment in US research and development.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
